Flower power

The timing of flowering in plants is affected by a wide range of hormonal, environmental and genetic factors. The semidominant fwa mutants are delayed in the transition to flowering. In the October Molecular Cell, Soppe et al. use positional cloning to isolate the Arabidopsis FWA gene, which encodes a homeodomain-containing protein (Molecular Cell 2000, 6:791-802). The late-flowering phenotype of the fwa mutants is caused by gain-of-function epi-alleles. Soppe et al. could find no differences

By | October 31, 2000

The timing of flowering in plants is affected by a wide range of hormonal, environmental and genetic factors. The semidominant fwa mutants are delayed in the transition to flowering. In the October Molecular Cell, Soppe et al. use positional cloning to isolate the Arabidopsis FWA gene, which encodes a homeodomain-containing protein (Molecular Cell 2000, 6:791-802). The late-flowering phenotype of the fwa mutants is caused by gain-of-function epi-alleles. Soppe et al. could find no differences in the genomic DNA sequence of the FWA gene. They show, however, that expression of the FWA gene is suppressed in mature wild-type plants because of extensive CG methylation and that ectopic expression in fwa mutants is characterized by stable hypomethylation of directly repeated sequences in the 5' region of the gene. These results provide insights into epigenetic regulation and represent good news for florists trying to understand the timing of flowering.

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham